on Eckert & Ziegler Strahlen- Und Medizintechnik AG (ETR:EUZ)
Eckert & Ziegler Gains Attention with Buy Rating and Strong Upside Potential
On April 14, 2026, B. Metzler seel. Sohn & Co. AG initiated coverage on Eckert & Ziegler SE, recommending a buy rating and setting the price target at €21.00. This suggests a 40.8% upside potential from the April 13 Xetra closing price of €14.92. Eckert & Ziegler, a key player in isotope-based components for nuclear medicine, is poised to benefit from increasing demand in diagnostic and therapeutic radioisotopes.
Metzler's coverage underscores the strong market position of Eckert & Ziegler. The company's shares are part of the TecDAX index of Deutsche Börse, reflecting its significance in the technology sector. With a wide array of services from development to distribution, Eckert & Ziegler plays a critical role in the radiopharmaceutical industry.
R. P.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Eckert & Ziegler Strahlen- Und Medizintechnik AG news